Covid-19 causes a range of symptoms and clinical trajectories. There are uncertainties related to what risk factors and comorbity profiles that associate with development of adverse outcomes,i.e. a acute respiratory disetress syndrome (ARDS) and diffuse alveolar damage, and mortality. This study aims to identify organ specific biomarkers, viral dynamics and immuneresponse in patients in patients infected with SARS-CoV2.